Correlation between the atellica SARS-COV-2 IGG assay results and the presence of SARS-COV-2 neutralizing antibodies

被引：0
|
作者：
Bedini, J. [2 ]
Filella, X. [1 ]
Hidalgo, S. [1 ]
Gonzalez-Escribano, C. [2 ]
机构：
[1] Hosp Clin Barcelona, Biochem & Mol Genet Dept, Barcelona, Spain
[2] Hosp Clin Barcelona, Core Lab, Barcelona, Spain
来源：
CLINICA CHIMICA ACTA | 2022年 / 530卷
关键词：
D O I：
10.1016/j.cca.2022.04.840
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
W102
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [21] Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
    Wang, Lidong
    Mohlenberg, Michelle
    Wang, Pengfei
    Zhou, Hao
    CYTOKINE & GROWTH FACTOR REVIEWS, 2023, 70 : 13 - 25
  • [22] Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy
    Zhou, Dongyan
    Zhou, Runhong
    Chen, Zhiwei
    IMMUNOTHERAPY ADVANCES, 2022, 2 (01):
  • [23] Human neutralizing antibodies elicited by SARS-CoV-2 infection
    Ju, Bin
    Zhang, Qi
    Ge, Jiwan
    Wang, Ruoke
    Sun, Jing
    Ge, Xiangyang
    Yu, Jiazhen
    Shan, Sisi
    Zhou, Bing
    Song, Shuo
    Tang, Xian
    Yu, Jinfang
    Lan, Jun
    Yuan, Jing
    Wang, Haiyan
    Zhao, Juanjuan
    Zhang, Shuye
    Wang, Youchun
    Shi, Xuanling
    Liu, Lei
    Zhao, Jincun
    Wang, Xinquan
    Zhang, Zheng
    Zhang, Linqi
    NATURE, 2020, 584 (7819) : 115 - +
  • [24] Neutralizing antibodies targeting SARS-CoV-2 spike protein
    Shi Xiaojie
    Li Yu
    Yan Lei
    Yang Guang
    Qiang Min
    STEM CELL RESEARCH, 2021, 50
  • [25] Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
    Tani, Hideki
    Kimura, Miyuki
    Tan, Long
    Yoshida, Yoshihiro
    Ozawa, Tatsuhiko
    Kishi, Hiroyuki
    Fukushi, Shuetsu
    Saijo, Masayuki
    Sano, Kaori
    Suzuki, Tadaki
    Kawasuji, Hitoshi
    Ueno, Akitoshi
    Miyajima, Yuki
    Fukui, Yasutaka
    Sakamaki, Ippei
    Yamamoto, Yoshihiro
    Morinaga, Yoshitomo
    VIROLOGY JOURNAL, 2021, 18 (01)
  • [26] Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects
    Manenti, Alessandro
    Gianchecchi, Elena
    Dapporto, Francesca
    Leonardi, Margherita
    Cantaloni, Paolo
    Fattorini, Filippo
    Piu, Pietro
    Bollati, Valentina
    Pastorino, Ugo
    Apolone, Giovanni
    Sozzi, Gabriella
    Montomoli, Emanuele
    JOURNAL OF IMMUNOLOGICAL METHODS, 2022, 500
  • [27] Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
    Wan, Jinkai
    Xing, Shenghui
    Ding, Longfei
    Wang, Yongheng
    Gu, Chenjian
    Wu, Yanling
    Rong, Bowen
    Li, Cheng
    Wang, Siqing
    Chen, Kun
    He, Chenxi
    Zhu, Dandan
    Yuan, Songhua
    Qiu, Chengli
    Zhao, Chen
    Nie, Lei
    Gao, Zhangzhao
    Jiao, Jingyu
    Zhang, Xiaoyan
    Wang, Xiangxi
    Ying, Tianlei
    Wang, Haibin
    Xie, Youhua
    Lu, Yanan
    Xu, Jianqing
    Lan, Fei
    CELL REPORTS, 2020, 32 (03):
  • [28] Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
    Hideki Tani
    Miyuki Kimura
    Long Tan
    Yoshihiro Yoshida
    Tatsuhiko Ozawa
    Hiroyuki Kishi
    Shuetsu Fukushi
    Masayuki Saijo
    Kaori Sano
    Tadaki Suzuki
    Hitoshi Kawasuji
    Akitoshi Ueno
    Yuki Miyajima
    Yasutaka Fukui
    Ippei Sakamaki
    Yoshihiro Yamamoto
    Yoshitomo Morinaga
    Virology Journal, 18
  • [29] Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
    Tang, Mei San
    Case, James Brett
    Franks, Caroline E.
    Chen, Rita E.
    Anderson, Neil W.
    Henderson, Jeffrey P.
    Diamond, Michael S.
    Gronowski, Ann M.
    Farnsworth, Christopher W.
    CLINICAL CHEMISTRY, 2020, 66 (12) : 1538 - 1547
  • [30] Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
    Lin, Qingqing
    Zhu, Li
    Ni, Zuowei
    Meng, Haitao
    You, Liangshun
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (05) : 821 - 822
12345